I stumbled across this which doing some research into this...

I stumbled across this which doing some research into this company:

http://additivebiomanufacturing.org/wp-content/uploads/2019/06/Sm_Advertorial-Osteopore_S887.pdf

Some key takeaways from recent media coverage:

• Proprietary technology, a proven use case
• Track record of successful clinical experience in craniofacial application spanning 12 years
• Osteopore has successfully commercialised three products, 'Osteoplug' 'Osteomesh' and 'Osteostrip' and has sold and successfully implanted over 20,000 units to hospitals in Singapore, South Korea, Vietnam and Malaysia since inception
• This technology can help minimise or totally eliminate future secondary treatments or revision surgeries, and their associated costly fees
• The company secured permits from regulators, including the US-510k FDA, CE Mark and KFDA, for craniofacial applications, as well as published 10-year successful clinical outcomes
• In 2004, Osteopore received the Far Eastern Economic Review Gold Award; in 2016, the company was named Entrepreneurial Company of the Year by Frost & Sullivan Singapore; and in 2017, it was recognised as a Company with Cutting Edge Technology by IQVIA.
• Targeting an addressable market of more than $100 billion